Area of research
Genetics · Pulmonary and Respiratory Medicine
Research interest
Research interests include Medicine, Biology, Internal medicine, Cancer research, Glioma, and Glioblastoma.
Consensus molecular subtyping of colorectal carcinoma brain metastases reveals a metabolic signature associated with poor patient survival
Dietary habits in relation to outcome and therapy-related toxicity in patients with glioblastoma – a retrospective cohort study
OGCT-04 PROSPECTIVE IMAGING-GUIDED BIOPSY TRIAL OF THE MACRO METASTASIS-BRAIN PARENCHYMA INTERFACE (METINFILT STUDY)
P14.04.A CHARACTERISTIC FEATURES OF PATIENTS WITH AUTOIMMUNE DIFFERENTIAL DIAGNOSES FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
Imaging–guided prospective biopsy trial of the macro metastasis–brain parenchyma interface highlighting the importance of the histological growth pattern in brain metastases
The role of neurosurgery for brain metastases between 2012 and 2022: Results of the multicenter <i>SUBAROMA</i> study
Health-Related Quality of Life and Treatment Satisfaction of Patients with Malignant IDH Wild-Type Gliomas and Their Caregivers
Effect of antibiotic drug use on outcome and therapy-related toxicity in patients with glioblastoma—A retrospective cohort study
CTNI-40. PSYCHOLOGICAL DOMAINS CORRELATE WITH ADHERENCE IN TTFIELDS TREATMENT OF GLIOBLASTOMA
Safety and efficacy of tumor treating fields (TTFields) prior and concomitant to radiotherapy in patients with newly diagnosed glioblastoma: Results from PriCoTTF.
Does the distance to the cancer center affect psycho-oncological care and emergency visits of patients with IDH wild-type gliomas? A retrospective study
Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre
Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal Origin
CTNI-29. INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL
QOL-02. FACTORS INFLUENCING COMPLIANCE IN TTF TREATMENT – THE COMPTUNE STUDY
Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite
CNTM-03. Functional connectivity networks in patients with brain tumors and vascular lesions in the occipital cortex
CBIO-01. INHIBITION OF EXTRACELLULAR CARBONIC ANHYDRASES INHIBITS GLIOBLASTOMA CELL INVASION
Abstract CT106: PriCoTTF trial: A phase I/II trial of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma
Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal Origin
PI3K: A master regulator of brain metastasis‐promoting macrophages/microglia
Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma
Information needs and requirements in patients with brain tumours and their relatives
HOUT-06. TTFIELDS FOR NEWLY DIAGNOSED GLIOBLASTOMA: IMPACT OF CONSULTATION STRATEGY
RARE-10. MULTICENTER PILOT STUDY OF RADIO-CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH MEDULLOBLASTOMA – THE NOA-07 TRIAL
ANGI-06. CHARACTERISATION OF INVASION OF HUMAN BRAIN TUMOUR INITIATING CELLS IN HUMAN GLIOBLASTOMA
ACTR-20. FINDING A PREDICTIVE MARKER FOR COMPLIANCE TO TTFIELDS THERAPY – THE COMPTUNE STUDY
Epileptic Activity Increases Cerebral Amino Acid Transport Assessed by <sup>18</sup>F-Fluoroethyl-l-Tyrosine Amino Acid PET: A Potential Brain Tumor Mimic
Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2
Quantitative Imaging of D-2-Hydroxyglutarate in Selected Histological Tissue Areas by a Novel Bioluminescence Technique